Additional safety information MHRA (April 2016): Updated advice on the risk of diabetic ketoacidosis MHRA (March 2017): Updated advice on increased risk of lower-limb amputations (mainly toes) MHRA (February 2019): Reports of Fourniers gangrene (necrotising fasciitis of the genitalia or perineum) MHRA (March 2020): Monitor ketones in blood during treatment interruptions for surgical procedures or acute serious medical illness Key summary table See also Need to know guide: SGLT2 inhibitors: Indications, doses and licences in adults How to: How to use SGLT2 inhibitors safely and effectively
This product is supplied strictly for research purposes and is not marketed as a weight loss treatment or consumer medication
Laboratory assessment Specimen Collection: Blood collection was performed with care to avoid stasis, hemolysis or contamination by tissue fluids, or exposure to glass
Confirm that the product fits your professional protocol, staff training, and documentation standards before scheduling treatment use
What is Tirzepatide, and how does it work?notobella-admin2024-11-05T02:35:27-08:00 Tirzepatide is a medication that helps with weight loss by mimicking the effects of a hormone called GLP-1, which regulates appetite and blood sugar levels